Skip to content
Home/Companies/Biotech/Violet Therapeutics
VT

Violet Therapeutics

Biotech·United States·Active·3yr hold

Violet Therapeutics is a biotech company, headquartered in United States.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Violet Therapeutics?

Violet Therapeutics is currently owned by SV Health Managers through Dementia Discovery Fund 2 (2025 vintage), since 2023.

Hand-verified · updated 2026-07-07

SV Health Managers
Investor
SV Health Managers
Dementia Discovery Fund 2 · 2025 · Impact

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Dementia Discovery Fund 2

Other portfolio companies in the same fund.

Leal Therapeutics
Active
BiotechUnited States· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings